The US Food and Drug Administration (FDA) has approved Venlafaxine HCl ER, a generic version of Wyeth’s antidepressant medication Effexor XR.

Israel-based Teva Pharmaceutical Industries has been given a 180-day period of marketing exclusivity for the generic capsules. Shipment is expected to begin in July 2010.

Effexor XR is used to treat major depressive disorder, generalised anxiety disorder, panic disorder and social anxiety disorder.

Pharmaceutical intelligence agency IMS Health estimates that Effexor XR had annual sales of $2.75bn in the US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData